Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. IJ Pharmaceutical Research
  4. Articles

  5. Epidrug Modulated Expression of MiR­-152 and MiR-148a Reverse Cisplatin Resistance in Ovarian Cancer Cells: An Experimental In-vitro Study
  6. Scopus by Title (Ref)

IJ Pharmaceutical Research

homeHome
play_arrowCurrent Issueformat_list_bulletedAll Issuesformat_indent_increaseIn Presscheck_boxAccepted Manuscripts
searchSearchqr_codeInstructions
bookmarkJournal InformationgroupsEditors & BoardsshareIndexing and Listing Sourceswaterfall_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
menuAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Regulation and function of microRNA-152 in various types of cancers: its upstream regulators and downstream targets

- Jafarzadeh S. , et al.

2. Mechanism of microRNA-152-3p-Mediated Regulation of Autophagy and Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells

- Wu D. , et al.

3. The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer

- Mondal P. , et al.

4. A Novel Competing Endogenous RNA Network Reveals Potential Mechanisms and Biomarkers of Chemoresistance in Lung Adenocarcinoma

- Liu W. , et al.

5. MICRORNA MIR-152 METHYLATION IN PATIENTS WITH OVARIAN CANCER: PROGNOSTIC POTENTIAL ANALYSIS

- Fedorova Y.Y. , et al.

6. Current data and future perspectives on DNA methylation in ovarian cancer (Review)

- Fu M. , et al.

7. MiR-375 promotes cisplatin sensitivity of lung adenocarcinoma

- Du S. , et al.

8. Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?

- Farani M.R. , et al.

9. Evodiamine inhibits malignant progression of ovarian cancer cells by regulating lncRNA-NEAT1/miR-152-3p/CDK19 axis

- Mao M. , et al.

10. miR-497-5p/SALL4 axis promotes stemness phenotype of choriocarcinoma and forms a feedback loop with DNMT-mediated epigenetic regulation

- Peng Z. , et al.

11. Investigation of epigenetic modifier on HDAC1 and microRNA-410 expression in ovarian cancer cell lines

- Sarkargar F. , et al.

HomeSearchInstructionsAPC

Archives

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.